Amrize Ltd
AMRZ NYSE Cement, Hydraulic Financials FY2023βFY2025
What Amrize Ltd does
No business description yet.
- Legal name
- Amrize Ltd
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 18, 2026
- Accession Β· CIK
- 0002035989-26-000017
0002035989
Revenue and margins
Amrize Ltd had $11.8B of revenue in fiscal 2025, up 0.9% on the year before.
Net income and earnings per share
From fiscal 2023 to 2025, diluted EPS grew 11.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.4B in fiscal 2025, 12.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Amrize Ltd returned β to shareholders in fiscal 2025. The diluted share count rose 0.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Amrize Ltd can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $1.1B | $1.6B | $1.9B |
| Debt incl. finance leases | β | $0.0M | $5.7B |
| Net debt / EBITDA | β | β0.5x | 1.4x |
| Debt / equity | β | 0.0x | 0.4x |
| Interest coverage | 3.3x | 4.0x | 4.1x |
| Current ratio | β | 1.9x | 1.6x |
| Quick ratio | β | 1.3x | 1.1x |
| Total assets | β | $23.8B | $24.2B |
| Total liabilities | β | $13.9B | $11.1B |
| Shareholders' equity | $9.2B | $9.9B | $13.1B |
| Net debt (β = net cash) | β | β$1.6B | $3.8B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 5 | 3 / 9 |
| Accruals ratio | β | β4.2% | β4.3% |
| Altman Z'' | β | 1.98 | 2.37 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $11.7B | $11.7B | $11.8B |
| Gross profit | $2.8B | $3.1B | $3.0B |
| Operating income | $1.9B | $2.2B | $1.9B |
| Interest expense | $564M | $547M | $461M |
| Pretax income | $1.3B | $1.6B | $1.5B |
| Income tax | $361M | $368M | $326M |
| Net income | $956M | $1.3B | $1.2B |
| Diluted EPS | $1.73 | $2.30 | $2.14 |
| Diluted shares | 0.55B | 0.55B | 0.55B |
| Cash flow | |||
| Cash from operations | $2.0B | $2.3B | $2.2B |
| Capital expenditure | $630M | $642M | $788M |
| Free cash flow | $1.4B | $1.6B | $1.4B |
| Depreciation and amortization | $689M | $736M | $758M |
| Stock-based compensation | $5.0M | $6.0M | $14.0M |
| Acquisitions | $1.6B | $249M | $86.0M |
| Balance sheet | |||
| Cash and short-term investments | $1.1B | $1.6B | $1.9B |
| Total debt | β | $0.0M | $5.3B |
| Finance lease liabilities | β | β | $438M |
| Current assets | β | $4.8B | $4.6B |
| Current liabilities | β | $2.6B | $2.9B |
| Inventory | β | $1.5B | $1.5B |
| Goodwill | $9.0B | $8.9B | $9.0B |
| Intangible assets | β | $1.8B | $1.7B |
| Total assets | β | $23.8B | $24.2B |
| Total liabilities | β | $13.9B | $11.1B |
| Shareholders' equity | $9.2B | $9.9B | $13.1B |
| Margins | |||
| Gross margin | 23.7% | 26.2% | 25.7% |
| Operating margin | 16.2% | 18.8% | 16.1% |
| EBITDA margin | 22.1% | 25.0% | 22.5% |
| Net margin | 8.2% | 10.9% | 10.0% |
| FCF margin | 12.0% | 14.0% | 12.0% |
| Returns | |||
| Return on capital | β | 20.4% | 9.1% |
| Return on capital employed | β | 10.3% | 8.9% |
| Return on equity | 10.4% | 13.3% | 10.3% |
| Return on assets | β | 5.4% | 4.9% |
| Return on tangible equity | 410.3% | β | 50.4% |
| Growth | |||
| Revenue growth | β | 0.2% | 0.9% |
| Net income growth | β | 33.3% | β7.0% |
| EPS growth | β | 32.9% | β7.0% |
| FCF growth | β | 16.6% | β13.4% |
| Share count change | β | 0.0% | 0.1% |
| Financial health | |||
| Net debt / EBITDA | β | β0.5x | 1.4x |
| Debt / equity | β | 0.0x | 0.4x |
| Interest coverage | 3.3x | 4.0x | 4.1x |
| Current ratio | β | 1.9x | 1.6x |
| Quick ratio | β | 1.3x | 1.1x |
| Capital allocation | |||
| Capex / revenue | 5.4% | 5.5% | 6.7% |
| Stock comp / revenue | 0.0% | 0.1% | 0.1% |
| Quality scores | |||
| Piotroski F-score | β | β | 3.0 |
| Altman Z'' | β | 2.0 | 2.4 |
| Accruals ratio | β | β4.2% | β4.3% |
Source: SEC EDGAR XBRL filings (CIK 0002035989). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.